E. Erkilic Et Al. , "Does remifentanil attenuate renal ischemia-reperfusion injury better than dexmedetomidine in rat kidney?," DRUG DESIGN DEVELOPMENT AND THERAPY , vol.11, pp.677-683, 2017
Erkilic, E. Et Al. 2017. Does remifentanil attenuate renal ischemia-reperfusion injury better than dexmedetomidine in rat kidney?. DRUG DESIGN DEVELOPMENT AND THERAPY , vol.11 , 677-683.
Erkilic, E., Kesimci, E., Alaybeyoglu, F., Kilinc, I., Tural, R., Yazgan, A., ... Gumus, T.(2017). Does remifentanil attenuate renal ischemia-reperfusion injury better than dexmedetomidine in rat kidney?. DRUG DESIGN DEVELOPMENT AND THERAPY , vol.11, 677-683.
Erkilic, E. Et Al. "Does remifentanil attenuate renal ischemia-reperfusion injury better than dexmedetomidine in rat kidney?," DRUG DESIGN DEVELOPMENT AND THERAPY , vol.11, 677-683, 2017
Erkilic, E. Et Al. "Does remifentanil attenuate renal ischemia-reperfusion injury better than dexmedetomidine in rat kidney?." DRUG DESIGN DEVELOPMENT AND THERAPY , vol.11, pp.677-683, 2017
Erkilic, E. Et Al. (2017) . "Does remifentanil attenuate renal ischemia-reperfusion injury better than dexmedetomidine in rat kidney?." DRUG DESIGN DEVELOPMENT AND THERAPY , vol.11, pp.677-683.
@article{article, author={E. Erkilic Et Al. }, title={Does remifentanil attenuate renal ischemia-reperfusion injury better than dexmedetomidine in rat kidney?}, journal={DRUG DESIGN DEVELOPMENT AND THERAPY}, year=2017, pages={677-683} }